Anti-HMGCR Myopathy

Anti-HMGCR myopathy was first recognized and characterized in patients with a history of statin exposure and immune-mediated necrotizing myopathy. After the discovery of anti-HMGCR autoantibodies, several international groups identified and characterized more patients, expanding the phenotypic spect...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohassel, Payam, Mammen, Andrew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836404/
https://www.ncbi.nlm.nih.gov/pubmed/29480216
http://dx.doi.org/10.3233/JND-170282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836404/
https://www.ncbi.nlm.nih.gov/pubmed/29480216
http://dx.doi.org/10.3233/JND-170282

Ejemplares similares